These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

588 related items for PubMed ID: 7912070

  • 1. Differential roles of cytochromes P450 2D1, 2C11, and 1A1/2 in the hydroxylation of bufuralol by rat liver microsomes.
    Mimura M, Yamazaki H, Sugahara C, Hiroi T, Funae Y, Shimada T.
    Biochem Pharmacol; 1994 Jun 01; 47(11):1957-63. PubMed ID: 7912070
    [Abstract] [Full Text] [Related]

  • 2. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
    Yamazaki H, Guo Z, Persmark M, Mimura M, Inoue K, Guengerich FP, Shimada T.
    Mol Pharmacol; 1994 Sep 01; 46(3):568-77. PubMed ID: 7935340
    [Abstract] [Full Text] [Related]

  • 3. Cytochrome P450 enzymes involved in the enhancement of propranolol N-desisopropylation after repeated administration of propranolol in rats.
    Narimatsu S, Mochida M, Matsumoto T, Masubuchi Y, Horie T, Nagata K, Funae Y, Cho AK, Suzuki T.
    Chem Biol Interact; 1996 Sep 06; 101(3):207-24. PubMed ID: 8870689
    [Abstract] [Full Text] [Related]

  • 4. Cytochrome P450 mediated bioactivation of methyleugenol to 1'-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes.
    Gardner I, Wakazono H, Bergin P, de Waziers I, Beaune P, Kenna JG, Caldwell J.
    Carcinogenesis; 1997 Sep 06; 18(9):1775-83. PubMed ID: 9328175
    [Abstract] [Full Text] [Related]

  • 5. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
    Meyer UA, Gut J, Kronbach T, Skoda C, Meier UT, Catin T, Dayer P.
    Xenobiotica; 1986 May 06; 16(5):449-64. PubMed ID: 2874666
    [Abstract] [Full Text] [Related]

  • 6. Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes.
    Kerlan V, Dreano Y, Bercovici JP, Beaune PH, Floch HH, Berthou F.
    Biochem Pharmacol; 1992 Nov 03; 44(9):1745-56. PubMed ID: 1449532
    [Abstract] [Full Text] [Related]

  • 7. (+)-bufuralol 1'-hydroxylation activity in human and rhesus monkey intestine and liver.
    Prueksaritanont T, Dwyer LM, Cribb AE.
    Biochem Pharmacol; 1995 Oct 26; 50(9):1521-5. PubMed ID: 7503805
    [Abstract] [Full Text] [Related]

  • 8. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
    Arlt VM, Hewer A, Sorg BL, Schmeiser HH, Phillips DH, Stiborova M.
    Chem Res Toxicol; 2004 Aug 26; 17(8):1092-101. PubMed ID: 15310241
    [Abstract] [Full Text] [Related]

  • 9. Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylation.
    Gut J, Gasser R, Dayer P, Kronbach T, Catin T, Meyer UA.
    FEBS Lett; 1984 Aug 06; 173(2):287-90. PubMed ID: 6146537
    [Abstract] [Full Text] [Related]

  • 10. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline.
    Murray M.
    Mol Pharmacol; 1992 Nov 06; 42(5):931-8. PubMed ID: 1435757
    [Abstract] [Full Text] [Related]

  • 11. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
    Bullock P, Pearce R, Draper A, Podval J, Bracken W, Veltman J, Thomas P, Parkinson A.
    Drug Metab Dispos; 1995 Jul 06; 23(7):736-48. PubMed ID: 7587963
    [Abstract] [Full Text] [Related]

  • 12. Catalytic specificity of CYP2D isoforms in rat and human.
    Hiroi T, Chow T, Imaoka S, Funae Y.
    Drug Metab Dispos; 2002 Sep 06; 30(9):970-6. PubMed ID: 12167561
    [Abstract] [Full Text] [Related]

  • 13. Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants.
    Murray M, Field SL.
    Biochem Pharmacol; 1992 May 28; 43(10):2065-71. PubMed ID: 1599495
    [Abstract] [Full Text] [Related]

  • 14. Catalytic activities of cytochrome P450 enzymes and UDP-glucuronosyltransferases involved in drug metabolism in rat everted sacs and intestinal microsomes.
    Takemoto K, Yamazaki H, Tanaka Y, Nakajima M, Yokoi T.
    Xenobiotica; 2003 Jan 28; 33(1):43-55. PubMed ID: 12519693
    [Abstract] [Full Text] [Related]

  • 15. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans.
    Shimada T, Mimura M, Inoue K, Nakamura S, Oda H, Ohmori S, Yamazaki H.
    Arch Toxicol; 1997 Jan 28; 71(6):401-8. PubMed ID: 9195021
    [Abstract] [Full Text] [Related]

  • 16. Characteristic properties of a retinoic acid synthetic cytochrome P-450 purified from liver microsomes of 3-methylcholanthrene-induced rats.
    Tomita S, Okuyama E, Ohnishi T, Ichikawa Y.
    Biochim Biophys Acta; 1996 Aug 13; 1290(3):273-81. PubMed ID: 8765131
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activation of amino-alpha-carboline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes.
    Shimada T, Guengerich FP.
    Cancer Res; 1991 Oct 01; 51(19):5284-91. PubMed ID: 1913651
    [Abstract] [Full Text] [Related]

  • 19. Roles of different forms of cytochrome P450 in the activation of the promutagen 6-aminochrysene to genotoxic metabolites in human liver microsomes.
    Yamazaki H, Mimura M, Oda Y, Inui Y, Shiraga T, Iwasaki K, Guengerich FP, Shimada T.
    Carcinogenesis; 1993 Jul 01; 14(7):1271-8. PubMed ID: 8330339
    [Abstract] [Full Text] [Related]

  • 20. Debrisoquine/sparteine-type polymorphism of drug oxidation. Purification and characterization of two functionally different human liver cytochrome P-450 isozymes involved in impaired hydroxylation of the prototype substrate bufuralol.
    Gut J, Catin T, Dayer P, Kronbach T, Zanger U, Meyer UA.
    J Biol Chem; 1986 Sep 05; 261(25):11734-43. PubMed ID: 3745165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.